Photo courtesy of Aspen Neuroscience.
Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.

Photo courtesy of Aspen Neuroscience. Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.

Aspen Neuroscience, a private biotech company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, announced the close of its Series A funding round of $70 million...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99